Glucose monitoring technologies for the intensive care unit

Care of the Critically Ill

Volumn 23, Issue 3, 2007, Pages 65-78

  Imhoff, Michael ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Blood glucose monitoring; Intensive care medicine; Sensor technology; Tight glucose control

Indexed keywords

GLUCOSE; GLUCOSE OXIDASE; HEXOKINASE;

ACCURACY; ANALYTICAL EQUIPMENT; BLOOD GLUCOSE MONITORING; CHEMOLUMINESCENCE; COLORIMETRY; CRITICALLY ILL PATIENT; DIABETES CONTROL; ELECTROCHEMICAL DETECTION; ENZYMATIC ASSAY; GLUCOSE BLOOD LEVEL; INTENSIVE CARE; INTENSIVE CARE UNIT; INTERSTITIAL FLUID; LABORATORY TEST; PHOTOACOUSTIC SPECTROSCOPY; RESPONSE TIME; REVIEW; SENSOR; TEST STRIP;

EID: 34447259097     PISSN: 02660970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001; 345: 1359-67.
2. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004; 79: 992-1000.
3. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-61.
4. Jenkins I. Swing low, sweet chariot, ... Intensive Care Monitor 13:56.
5. Malhotra A. Intensive insulin in intensive care. N Engl J Med 2006; 354: 516-8.
6. Angus DC, Abraham E. Intensive insulin therapy in critical illness. Am J Respir Crit Care Med 2005; 172: 1358-9.
7. Mackenzie I, Ingle S, Zaidi S, Buczaski S. Tight glycaemic control: a survey of intensive care practice in large English hospitals. Intensive Care Med 2005; 31: 1136.
8. Brunkhorst FM, Kuhnt E, Engel C, Meier-Hellmann A, Ragaller M, Quintel M, Weiler N, Gründling M, Oppert M, Deufel T, Löffler M, Reinhart K, and the German Competence Network Sepsis (SepNet). Intensive insulin therapy in patient with severe sepsis and septic shock is associated with an increased rate of hypoglycemia - results from a randomized multicenter study (VISEP). Infection 2005? 33 (Suppl 1): 19.
9. Mackenzie I, Ingle S, Zaidi S, Buczaski S. Hypoglycaemia? So what! Intensive Care Med 2006; 32: 620-1.
10. Van den Berghe G. First do no harm ... hypoglycemia or hyperglycemia? Crit Care Med 2006;34: 2843-4.
11. Vriesendorp TM, DeVries JH, van Santen S, Moeniralam HS, de Jonge E, Roos YB, Schultz MJ, Rosendaal FR, Hoekstra JB. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 2006; 34: 2714-8.
12. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet Med 2006; 23: 1-12.
13. Corstjens AM, Ligtenberg JJ, van der Horst IC, Spanjersberg R, Lind JS, Tulleken JE, Meertens JH, Zijlstra JG. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care 2006; 10: R135.
14. Ellmerer M, Haluzik M, Blaha J, Kremen J, Svacina S, Toller W, Mader J, Schaupp L, Plank J, Pieber T. Clinical evaluation of alternative-site glucose measurements in patients after major cardiac surgery. Diabetes Care 2006; 29: 1275-81.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 8476: 307-10.
16. Cox DJ, Clarke WL, Gonder-Frederick L, Pohl S, Hoover C, Snyder A, Zimbelman L, Carter WR, Bobbin S, Pennebaker J. Accuracy of perceiving blood glucose in IDDM. Diabetes Care 1985; 8: 529-36.
17. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987; 10: 622-8.
18. Plank J, Blaha J, Cordingley J, Wilinska ME, Chassin LJ, Morgan C, Squire S, Haluzik M, Kremen J, Svacina S, Toller W, Plasnik A, Ellmerer M, Hovorka R, Pieber TR. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care 2006; 29: 271-6.
19. Finkielman JD, Oyen LJ, Afessa B. Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest 2005; 127: 1749-51.
20. Koschinsky T, Jungheim K, Heinemann L. Glucose sensors and the alternate site testing-like phenomenon: relationship between rapid blood glucose changes and glucose sensor signals. Diabetes Technol Ther 2003; 5: 829-42.
21. Weiss R, Kerem E, Sorkine P, Stocki D, Adi N. Evaluation of a new glucose monitoring device for the critical care setting. Crit Care Med 2006; 34 (12 suppl): A67.
22. Newman P, Musceder J, Heyland D, Drover J, Houlden R, Day A, Su Y. Evaluation of a continuous glucose monitoring system in critically ill adult patients. Crit Care Med 2006; 34 (12 suppl): A66
23. Sieg A, Guy RH, Delgado-Charro MB. Noninvasive and minimally invasive methods for transdermal glucose monitoring. Diabetes Technol Ther 2005; 7: 174-97.
24. Khalil OS. Non-invasive glucose measurement technologies: an update from 1999 to the dawn of the new millennium. Diabetes Technol Ther 2004; 6: 660-97.
25. Wickramasinghe Y, Yang Y, Spencer SA. Current problems and potential techniques in in vivo glucose monitoring. J Fluoresc 2004; 14: 513-20.
26. Collison ME, Meyerhoff ME. Chemical sensors for bedside monitoring of critically ill patients. Anal Chem 1990; 62: 425A-437A.
27. Meyerhoff ME. New in vitro analytical approaches for clinical chemistry measurements in critical care. Clin Chem 1990; 36: 1567-72.
28. McShane MJ. Potential for glucose monitoring with nanoengineered fluorescent biosensors. Diabetes Technol Ther 2002; 4: 533-8.
29. Badugu R, Lakowicz JR, Geddes CD. Ophthalmic glucose monitoring using disposable contact lenses - a review. J Fluoresc 2004; 14: 617-33.
30. De Block C, Manuel-Y-Keenoy B, Van Gaal L, Rogiers P. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care 2006; 29: 1750-6.
31. Rauhut MM. Chemiluminescence. In: Grayson M, editor. Kirk-Othmer Concise Encyclopedia of Chemical Technology (3rd ed). New York: John Wiley; 1989. p 247.
32. Liu W, Zhang Z, Liu H. Droplet-based micro-flow chemiluminescence system for in-vivo glucose determination by microflow sampling. Anal Sci 2005; 21: 413-6.
33. McNichols RJ, Cote GL. Optical glucose sensing in biological fluids: an overview. J Biomed Opt 2000; 5: 5-16.
34. Berman HL, Roe JN, inventors. Infrared ATR glucose measurement system (II). United States patent application 2002015773. October 17, 2002.
35. Arnold MA. Non-invasive glucose monitoring. Curr Opin Biotechnol 1996; 7: 46-9.
36. Cote GL. Noninvasive and minimally-invasive optical monitoring technologies. J Nutr 2001; 131: 1596S-604S.
37. Kost J, Mitragotri S, Gabbay RA, Pishko M, Langer R. Transdermal monitoring of glucose and other analytes using ultrasound. Nat Med. 2000; 6: 347-50.
38. Lambert JL, Morrokain JM, Sirk SJ, Borchert MS. Measurement of aqueous glucose in a model anterior chamber using Raman spectroscopy. J Raman Spectrosc 2002; 33: 524-529.
39. Wicksted JP, Erckens RJ, Motamedi M, March W. Monitoring of aqueous humour metabolites using Raman spectroscopy. Proc SP1E 1994; 2135: 264-74.
40. Sodickson LA, Block MJ. Kromoscopic analysis: a possible alternative to spectroscopic analysis for noninvasive measurement of analytes in vivo. Clin Chem 1994; 40: 1838-44.
41. Chaiken J, Peterson CM, inventors; LighTouch Medical, Inc., assignee. Method for non-invasive measurement of an analyte. United States patent 6,377,828. April 23, 2002.
42. Chaiken J, Peterson CM, inventors; LighTouch Medical, Inc., assignee. Method for non-invasive meaurement of an analyte. United States patent 6,044,285. March 28, 2000.
43. Hanlon EB, Manoharan R, Koo TW, Shafer KE, Motz JT, Fitzmaurice M, Kramer JR, Itzkan I, Dasari RR, Feld MS. Prospects for in vivo Raman spectroscopy. Phys Med Biol 2000; 45: R1-59.
44. Steffes PG. Laser-based measurement of glucose in the ocular aqueous humor: an efficacious portal for determination of serum glucose levels. Diabetes Technol Ther 1999; 1: 129-33.
45. Enejder AM, Scecina TG, Oh J, Hunter M, Shih WC, Sasic S, Horowitz GL, Feld MS. Raman spectroscopy for noninvasive glucose measurements. J Biomed Opt 2005; 10: 031114.
46. Zhao Z, Myllylä R. Photoacoustic determination of glucose concentration in whole blood by a near-infrared laser diode. Proc SPIE 2001; 4256: 77-83.
47. Nagar R, Pesach B, Ben-Ami U, inventors. Photoacoustic assay and imaging system. United States patent 6,846,288. January 25, 2005.
48. Pesach B, Nagar R, Belfer I, Argaman D, Askenazi S, Adoram A, Roffeh Y. Continuous non-invasive venous blood glucose monitor. Diabetes Technol Ther 2003; 5: 264.
49. Raz I, Wainstain J, Argaman D. Continuous non-invasive venous blood glucose monitor. Diabetes 2003; 52(suppl 1): A98.
50. Weiss R, Yegorchikov Y, Shusterman A, Raz I. Noninvasive continuous glucose monitoring using photoacoustic technology-results from the first 62 subjects. Diabetes Technol Ther 2007; 9: 68-74.
51. Buchert JM, inventor. Non-invasive continuous blood glucose monitoring. United States patent 5,823,966. October 20, 1998.
52. Malchoff CD, Shoukri K, Landau JI, Buchert JM. A novel noninvasive blood glucose monitor. Diabetes Care 2002; 25: 2268-75.
53. Zheng P, Kramer CE, Barnes CW, Braig JR, Sterling BB. Noninvasive glucose determination by oscillating thermal gradient spectrometry. Diabetes Technol Ther 2000; 2: 17-25.
54. Heinemann L, Schmelzeisen-Redeker G. Non-invasive continuous glucose monitoring in Type I diabetic patients with optical glucose sensors. Non-Invasive Task Force (NITF). Diabetologia 1998; 41: 848-54.
55. Heinemann L, Kramer U, Klotzer HM, Hein M, Volz D, Hermann M, Heise T, Rave K; Non-Invasive Task Force. Noninvasive glucose measurement by monitoring of scattering coefficient during oral glucose tolerance tests. Non-Invasive Task Force. Diabetes Technol Ther 2000; 2: 211-20.
56. Cohen O, Fine I, Monashkin E, Karasik A. Glucose correlation with light scattering patterns - a novel method for non-invasive glucose measurements. Diabetes Technol Ther 2003; 5: 11-7.
57. Fine I, Fikhte B, Shvartsman LD. Occlusion spectroscopy as a new paradigm for noninvasive blood measurements. Proc SPIE 2001; 4263: 122-130.
58. Yeh SJ, Khalil OS, Hanna CF, Kantor S. Near-infrared thermo-optical response of the localized reflectance of intact diabetic and nondiabetic human skin. J Biomed Opt 2003; 8: 534-44.
59. Khalil OS, Yeh SJ, Lowery MG, Wu X, Hanna CF, Kantor S, Jeng TW, Kanger JS, Bolt RA, de Mul FF. Temperature modulation of the visible and near infrared absorption and scattering coefficients of human skin. J Biomed Opt 2003; 8: 191-205.
60. Larin KV, Eledrisi MS, Motamedi M, Esenaliev RO. Noninvasive blood glucose monitoring with optical coherence tomography: a pilot study in human subjects. Diabetes Care 2002; 25: 2263-7.
61. Baba JS, Cooper CT, Cote GL. Modelling the rabbit's eye with the Mueller matrix for birefringent properties. Proc SPIE 2003; 4965: 104-10.
62. Cameron BD, Baba JS, Cote GL. Measurement of the glucose transport time delay between the blood and aqueous humor of the eye for the eventual development of a noninvasive glucose sensor. Diabetes Technol T her 2001; 3: 201-7.
63. Caduff A, Hirt E, Feldman Y, Ali Z, Heinemann L. First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. Biosens Bioelectron 2003; 19: 209-17.
64. Caduff A, Dewarrat F, Talary M, Stalder G, Heinemann L, Feldman Y. Non-invasive glucose monitoring in patients with diabetes: a novel system based on impedance spectroscopy. Biosens Bioelectron 2006; 22: 598-604.
65. Cho OK, Holzgreve B, inventors; OK Kyung Cho, assignee. Process and device for determining the exchange of heat between the human body and the invented device and its correlation to the glucose concentration in human blood. United States patent 5,924,996, July 20, 1999.
66. Goldberg PA, Siegel MD, Russell RR, Sherwin RS, Halickman JI, Cooper DA, Dziura JD, Inzucchi SE. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther 2004; 6: 339-47.
67. Lage SG, Canosa HG, Fernandez JG, Costa FF, Kopel L, Lopes JL, Murakami A, Guiraldelli R, Gutierrez MA. Real time continuous glucose monitoring system in a medical critical care unit. Crit Care Med 2006; 34 (12suppl): A68
68. Vriesendorp TM, DeVries JH, Holleman F, Dzoljic M, Hoekstra JB. The use of two continuous glucose sensors during and after surgery. Diabetes Technol Ther 2005; 7: 315-22.
69. Clarke WL, Anderson S, Farhy L, Breton M, Gonder-Frederick L, Cox D, Kovatchev B. Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care 2005; 28: 2412-7.
70. Weinstein RL, Schwartz SL, Brazg RL, Bugler JR, Peyser TA, McGarraugh GV. Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care 2007; 30: 1125-30.